For columnist Dagmar Munn, reducing uncertainty in one area of her life with ALS would mean keeping her ALS progression right where it is.

The news of Eric Dane’s death on Thursday at 53 came as a shock, but what’s unsettled many further is the reported speed of his illness. The actor, widely recognised for playing McSteamy on Grey’s ...

The growing burden of ALS in the US highlights the need for earlier diagnosis, multidisciplinary care, and expanded access to emerging therapies.

IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...

Eric Dane's death after battling ALS brings attention to the progressive illness affecting 5,000 Americans yearly with only a two to five year life expectancy.

A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...

Please provide your email address to receive an email when new articles are posted on . A new analysis of an overall survival study of an investigational immunotherapy platform to treat ALS found it ...

A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified ...

QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...

AB Science says a newly identified blood biomarker may help assess masitinib activity in its ongoing Phase 3 ALS clinical trial.

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...